Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 25;12:864790. doi: 10.3389/fonc.2022.864790

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Bodea, Caldwell and Federico

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Description of treatment duartion, clinical course, timing of dosing modifications, best response, disease progression of all osseous sarcomas and additional solid tumors with response (≥SD). *Details regarding dosing modifications and unique variables is further described for each case in Supplementary Materials . #EWS, Ewing sarcoma; OS, osteosarcoma; HGS, high grade sarcoma; CCM, clear cell meningioma; SS, synovial sarcoma; RT, rhabdoid tumor; HCC, hepatocellular carcinoma; DSRCT, desmoplastic small round cell tumors.